BioLineRx Ltd. / Fundamentals
Income statement
- Net revenue
€14.80M - Cost of goods sold
€6.02M - Gross profit
€8.78M - SG&A expenses
€11.98M - R&D expenses
€7.19M - EBITDA
€1.69M - D&A
€2.60M - EBIT
-€12.45M - Interest expenses
€5.80M - EBT
-€6.71M - Tax expenses
€0.00 - Net income
-€6.71M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€12.30M - Changes in working capital
-€2.13M - Operating cash flow
-€18.19M - Capex
-€5.15K - Other investing cash flow
-€858.00 - Net investing cash flow
€8.11M - Total cash dividends paid
€0.00 - Issuance of common stock
€20.89M - Debt repayment
-€13.42M - Other financing cash flow
€18.88K - Net financing cash flow
€7.49M - Foreign exchange effects
€508.79K - Net change in cash
-€2.09M - Cash at end of period
€6.17M - Free cash flow
-€18.20M
Balance sheet
- Cash and cash equivalents
€6.17M - Cash and short-term investments
€24.16M - Total receivables
€241.10K - Inventory
€2.45M - Other current assets
€490.78K - Total current assets
€27.34M - Property, plant & equipment
€855.43K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€9.79M - Total assets
€37.12M - Accounts payable
€2.97M - Short-term debt
€4.19M - Other current liabilities
€6.11M - Total current liabilities
€13.28M - Long-term debt
€6.62M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€6.62M - Total liabilities
€19.90M - Common stock
€61.62M - Retained earnings
-€342.03M - Other equity
€13.50M - Total equity
€17.22M - Total liabilities and shareholders' equity
€37.12M
Company information
- Market capitalization
€301.74M - Employees
28 - Enterprise Value
€25.34M
Company ratios
- Gross margin
-
59.3% Better than peer group: 51.0% - EBITDA margin
-
11.4% Much better than peer group: -1,212.8% - EBIT margin
-
-84.1% Much better than peer group: -1,290.1% - EBT margin
-
-45.3% Much better than peer group: -1,270.3% - Net margin
-
-45.3% Much better than peer group: -1,248.5% - ROE
-
-39.0% Even with peer group: -38.9% - ROA
-
-18.1% Better than peer group: -29.7% - Asset turnover
-
39.9% Much better than peer group: 19.7% - FCF margin
-
-122.9% Much better than peer group: -339.6% - FCF yield
-6.0% - Efficiency ratio
88.6% - Net sales per employee
-
€528.62K - Net income per employee
-
-€239.69K